Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Makers In Japan Want Price Cap Revisions

This article was originally published in PharmAsia News

Executive Summary

Japanese pharmaceutical makers are asking the government to reconsider its decision to lower the cap on drug prices by 5.2 percent. The new price limits, which are lower than the 6.7 percent decrease of two years ago, are set to take effect in April. Drug makers contend the lowered caps do not give adequate consideration to the cost of developing new drugs. Chugai Pharmaceutical estimates it will suffer a 7.2 percent reduction in the prices it can charge for its products. (Click here for more - a subscription may be required
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068017

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel